Literature DB >> 11036076

Interaction kinetics of reversible inhibitors and substrates with acetylcholinesterase and its fasciculin 2 complex.

Z Radić1, P Taylor.   

Abstract

Fasciculin 2 (Fas2), a three-fingered peptide of 61 amino acids, binds tightly to the peripheral site of acetylcholinesterases (AChE; EC ), occluding the entry portal into the active center gorge of the enzyme and inhibiting its catalytic activity. We investigated the mechanism of Fas2 inhibition by studying hydrolysis of cationic and neutral substrates and by determining the kinetics of interaction for fast equilibrating cationic and neutral reversible inhibitors with the AChE.Fas2 complex and free AChE. Catalytic parameters, derived by eliminating residual Fas2-resistant activity, reveal that Fas2 reduces k(cat)/K(m) up to 10(6)-fold for cationic substrates and less than 10(3)-fold for neutral substrates. Rate constants for association of reversible inhibitors with the active center of the AChE.Fas2 complex were reduced about 10(4)-fold for both cationic and neutral inhibitors, while dissociation rate constants were reduced 10(2)-to 10(3)-fold, compared with AChE alone. Rates of ligand association with both AChE and AChE.Fas2 complex were dependent on the protonation state of ionizable ligands but were also markedly reduced by protonation of enzyme residue(s) with pK(a) of 6.1-6.2. Linear free energy relationships between the equilibrium constant and the kinetic constants show that Fas2, presumably through an allosteric influence, markedly alters the position of the transition state in the reaction pathway. Since Fas2 complexation introduces an energetic barrier for hydrolysis of substrates that exceeds that found for association of reversible ligands, Fas2 influences catalytic parameters by a more complex mechanism than simple restriction of diffusional entry and exit from the active center. Conformational flexibility appears critical for facilitating ligand passage in the narrow active center gorge for both AChE and the AChE.Fas2 complex.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11036076     DOI: 10.1074/jbc.M006855200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  A new crystal form of human acetylcholinesterase for exploratory room-temperature crystallography studies.

Authors:  Oksana Gerlits; Kwok-Yiu Ho; Xiaolin Cheng; Donald Blumenthal; Palmer Taylor; Andrey Kovalevsky; Zoran Radić
Journal:  Chem Biol Interact       Date:  2019-06-07       Impact factor: 5.192

Review 2.  Protein-Catalyzed Capture Agents.

Authors:  Heather D Agnew; Matthew B Coppock; Matthew N Idso; Bert T Lai; JingXin Liang; Amy M McCarthy-Torrens; Carmen M Warren; James R Heath
Journal:  Chem Rev       Date:  2019-03-06       Impact factor: 60.622

3.  Interaction kinetics of oximes with native, phosphylated and aged human acetylcholinesterase.

Authors:  Zoran Radić; Jaroslaw Kalisiak; Valery V Fokin; K Barry Sharpless; Palmer Taylor
Journal:  Chem Biol Interact       Date:  2010-04-20       Impact factor: 5.192

4.  Tryptophan fluorescence reveals conformational changes in the acetylcholine binding protein.

Authors:  Scott B Hansen; Zoran Radic'; Todd T Talley; Brian E Molles; Tom Deerinck; Igor Tsigelny; Palmer Taylor
Journal:  J Biol Chem       Date:  2002-09-13       Impact factor: 5.157

5.  Automated docking with protein flexibility in the design of femtomolar "click chemistry" inhibitors of acetylcholinesterase.

Authors:  Garrett M Morris; Luke G Green; Zoran Radić; Palmer Taylor; K Barry Sharpless; Arthur J Olson; Flavio Grynszpan
Journal:  J Chem Inf Model       Date:  2013-03-29       Impact factor: 4.956

Review 6.  Limitations in current acetylcholinesterase structure-based design of oxime antidotes for organophosphate poisoning.

Authors:  Andrey Kovalevsky; Donald K Blumenthal; Xiaolin Cheng; Palmer Taylor; Zoran Radić
Journal:  Ann N Y Acad Sci       Date:  2016-07-02       Impact factor: 5.691

7.  Continuum simulations of acetylcholine diffusion with reaction-determined boundaries in neuromuscular junction models.

Authors:  Yuhui Cheng; Jason K Suen; Zoran Radić; Stephen D Bond; Michael J Holst; J Andrew McCammon
Journal:  Biophys Chem       Date:  2007-01-19       Impact factor: 2.352

8.  Expanding the palette of phenanthridinium cations.

Authors:  Andrew G Cairns; Hans Martin Senn; Michael P Murphy; Richard C Hartley
Journal:  Chemistry       Date:  2014-03-24       Impact factor: 5.236

9.  Potential new therapeutic modality revealed through agent-based modeling of the neuromuscular junction and acetylcholinesterase inhibition.

Authors:  Richard R Chapleau; Peter J Robinson; John J Schlager; Jeffery M Gearhart
Journal:  Theor Biol Med Model       Date:  2014-10-02       Impact factor: 2.432

10.  Acetylcholinesterase: mechanisms of covalent inhibition of H447I mutant determined by computational analyses.

Authors:  Y H Cheng; X L Cheng; Z Radić; J A McCammon
Journal:  Chem Biol Interact       Date:  2008-05-07       Impact factor: 5.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.